Skip to content

Juvenile Paralysis Agitans Of Hunt C0238344

Published: July 22, 2026Updated: August 20, 2026

An early-onset movement disorder causing progressive parkinsonism with tremor and muscle rigidity. Onset typically occurs in childhood or adolescence.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Postural instability

Bradykinesia

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Rigidity

(neurologic)

Resting tremor

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Dopaminergic Therapy

Levodopa and dopamine agonists remain the cornerstone of treatment for movement symptoms. Initiated at low doses with gradual titration based on response and tolerability.

medication
3

Intensive Physical Rehabilitation

Structured physical therapy focusing on gait training, balance exercises, and movement coordination. Regular sessions help maintain function and reduce disability.

physical_therapy

Additional treatment options

Adjunctive Symptom Management

Additional medications for associated symptoms such as tremor, rigidity, or mood disturbances may be prescribed as adjuncts to primary dopaminergic therapy.

medication

Neuropsychological Support

Assessment and support for cognitive and emotional aspects of the condition. Counseling and strategies to cope with chronic motor disability.

psychological

Longitudinal Neurological Follow-up

Regular specialist appointments to monitor disease progression, treatment efficacy, and adjust medications over time. May include imaging and functional assessments.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Juvenile Paralysis Agitans Of Hunt C0238344?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Juvenile Paralysis Agitans Of Hunt C0238344. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy